Effect of beta blocker therapy on survival of patients with heart failure and preserved systolic function following hospitalization with acute decompensated heart failure

European Journal of Internal Medicine

Volumn 23, Issue 4, 2012, Pages 374-378

  Nevzorov, Roman ^a   Porath, Avi ^b   Henkin, Yaakov ^c   Kobal, Sergio L ^c   Jotkowitz, Alan ^c   Novack, Victor ^c,d  

^a TEL AVIV UNIVERSITY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Beta blocker therapy; Decompensated heart failure; Heart failure with preserved systolic function

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; SPIRONOLACTONE; WARFARIN;

ACUTE HEART FAILURE; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PROTECTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COMORBIDITY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROPENSITY SCORE; RETROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL ANALYSIS; SYSTOLE;

EID: 84860536639     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2012.01.011     Document Type: Article

References (28)

1. R.S. Vasan, E.J. Benjamin, and D. Levy Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective J Am Coll Cardiol 26 1995 1565 1574
2. K.W. Dauterman, B.M. Massie, and M. Gheorghiade Heart failure associated with preserved systolic function: a common and costly clinical entity Am Heart J 135 1998 S310 S319
3. M.R. Zile, and D.L. Brutsaert New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis, and measurements of diastolic function Circulation 105 2002 1387 1393
4. W.H. Gaasch, and M.R. Zile Left ventricular diastolic dysfunction and diastolic heart failure Annu Rev Med 55 2004 373 394 Review
5. D.M. Henkel, M.M. Redfield, S.A. Weston, Y. Gerber, and V.L. Roger Death in heart failure: a community perspective Circ Heart Fail 1 2008 91 97
6. R.S. Bhatia, J.V. Tu, D.S. Lee, P.C. Austin, J. Fang, and A. Haouzi Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269
7. K. Hogg, K. Swedberg, and J. McMurray Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis J Am Coll Cardiol 43 2004 317 327 Review
8. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
9. O. Gorelic, D. Almoznino-Sarafian, M. Shteinshnaider, I. Alon, I. Tzur, and I. Sokolsky Clinical variables affecting survival in patients with decompensated diastolic versus systolic heart failure Clin Res Cardiol 98 2009 224 232
10. A. Ahmed, M.W. Rich, J.L. Fleg, M.R. Zile, J.B. Young, and D.W. Kitzman Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial Circulation 114 2006 397 403 Epub 2006 Jul 24
11. W.S. Aronow, and I. Kronzon Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction Am J Cardiol 71 1993 602 604
12. J.F. Setaro, B.L. Zaret, D.S. Schulman, H.R. Black, and R. Soufer Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance Am J Cardiol 66 1990 981 986
13. S. Yusuf, M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, and J.J. McMurray Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781
14. Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
15. CIBS Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBS-II): a randomized trial Lancet 353 1999 9 13
16. M. Packer, A.J. Coats, M.B. Fowler, H.A. Katus, H. Krum, and P. Mohacsi Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
17. A.F. Hernandez, B.G. Hammill, C.M. O'Connor, K.A. Schulman, L.H. Curtis, and G.C. Fonarow Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry J Am Coll Cardiol 53 2009 184 192
18. D.J. van Veldhuisen, A. Cohen-Solal, M. Böhm, S.D. Anker, D. Babalis, and M. Roughton SENIORS Investigators. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure) J Am Coll Cardiol 53 2009 2150 2158
19. J.S. Simonson, and N.B. Schiller Descent of the base of the left ventricle: an echocardiographic index of the left ventricular function J Am Soc Echocardiogr 2 1989 25 35
20. R.L. O'Connel, and L.L.Y. Lim Utility of the Charlson comorbidity index computed from routinely collected hospital discharge diagnosis codes Method Inform Med 39 2000 7 11
21. D.T. Smith, R. Farzaneh-Far, S. Ali, B. Na, M.A. Whooley, and N.B. Schiller Relation of beta-blocker use with frequency of hospitalization for heart failure in patients with left ventricular diastolic dysfunction (from the Heart and Soul Study) Am J Cardiol 105 2010 223 228
22. D.J. Duncker, and R.J. Bache Regulation of coronary vasomotor tone under normal conditions and during acute myocardial hypoperfusion Pharmacol Ther 86 2000 87 110
23. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, and T.G. Ganiats Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 e90
24. Erratum in: J Am Coll Cardiol 54 2009 2464
25. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, and P.A. Poole-Wilson Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442 Epub 2008 Sep 17. Review
26. A. Bergström, B. Andersson, M. Edner, E. Nylander, H. Persson, and U. Dahlström Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC) Eur J Heart Fail 6 2004 453 461
27. D. Burkhoff, M.S. Maurer, and M. Packer Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation 107 2003 656 658
28. O. Kamp, M. Metra, S. Bugatti, L. Bettari, A. Dei Cas, and N. Petrini Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release Drugs 70 2010 41 56